Celularity Inc. (NASDAQ: CELU)
$3.08
-0.1100 ( -3.45% ) 13.5K
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases.
Market Data
Open
$3.08
Previous close
$3.19
Volume
13.5K
Market cap
$67.09M
Day range
$3.00 - $3.28
52 week range
$1.59 - $7.97
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Feb 21, 2024 |
8-k | 8K-related | 16 | Feb 12, 2024 |
def | Proxies and info statements | 4 | Feb 02, 2024 |
pre | Proxies and info statements | 4 | Jan 23, 2024 |
8-k | 8K-related | 19 | Jan 17, 2024 |
4 | Insider transactions | 1 | Jan 17, 2024 |
8-k | 8K-related | 11 | Jan 09, 2024 |
10-q | Quarterly Reports | 94 | Jan 03, 2024 |
8-k | 8K-related | 13 | Dec 29, 2023 |
8-k | 8K-related | 13 | Nov 24, 2023 |